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Radiofrequency Ablation Using a
Monopolar Wet Electrode for the
Treatment of Inoperable Non-Small Cell
Lung Cancer: a Preliminary Report
Objective: To assess the technical feasibility and complications of radiofre-
quency ablation (RFA) using a monopolar wet electrode for the treatment of inop-
erable non-small cell lung malignancies.
Materials and Methods: Sixteen patients with a non-small cell lung malignan-
cy underwent RFA under CT guidance. All the patients were non-surgical candi-
dates, with mean maximum tumor diameters ranging from 3 to 6 cm (mean: 4.6
1.1 cm). A single 16-gauge open-perfused electrode with a 2 cm exposed tip
was used for the procedure. A 0.9% NaCl saline solution was used as the perfu-
sion liquid with the flow adjusted to 30 mL/h. The radiofrequency energy was
applied for 10 40 minutes. The response to RFA was evaluated by performing
contrast-enhanced CT immediately after RFA, one month after treatment and
then every three months thereafter.
Results: Technical failure was observed in six (37.5%) of 16 patients:
intractable pain (n = 2) and non-stop coughing (n = 4). The mean follow-up inter-
val was 15  8 months (range: 9 31 months). The mean maximum ablated
diameter in the technically successful group of patients ranged from 3.5 to 7.5 cm
(mean 5.1  1.3 cm). Complete necrosis was attained for eight (80%) of 10
lesions, and partial necrosis was achieved for two lesions. There were two major
complications (2/10, 20%) encountered: a hemothorax (n = 1) and a bron-
chopleural fistula (n = 1).
Conclusion: Although RFA using a monopolar wet electrode can create a
large ablation zone, it is associated with a high rate of technical failure when used
to treat inoperable non-small cell lung malignancies.
adiofrequency ablation (RFA) can offer physicians an attractive alterna-
tive for the treatment of patients with an inoperable lung malignancy.
The advantages of this technique include the ability to preserve more
lung tissue than is possible with a surgical resection, and there is reduced morbidity
compared with that associated with surgery. This is particularly important for patients
suffering from lung cancer as they usually have accompanying chronic obstructive
pulmonary disease. Some researchers (3 5) have suggested that RFA can be a
minimally invasive method for treating patients with inoperable lung cancer. It has
been reported that the incidence of complete coagulation necrosis of a lung
malignancy after RFA as seen at the follow-up computed tomography (CT) was 38
76% and the rate of complications, such as a pneumothorax and hemoptysis, was 10
91% (1 9).
The major limitations for performing RFA for a lung malignancy have been the
incapability of the technique to produce a coagulation area that is sufficiently large to
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Rinclude lung malignancies > 3 cm along with a reasonable
safety margin (5 10 mm) of the normal tissue (1 6). Lee
et al. (4) have reported that complete necrosis was attained
100% for tumors < 3 cm in size but complete necrosis was
obtained in only six of 26 larger tumors. In an attempt to
overcome this limitation of the ablated zone size, several
studies have demonstrated that saline-enhanced RFA has
showed superior performance in creating coagulation
necrosis in the liver and lung (10 15).
However, there are few reports evaluating saline-
enhanced RFA for a lung malignancy in humans. This
report describes our initial experience using a CT-guided,
transthoracic, RFA using a monopolar wet electrode for
the treatment of inoperable non-small cell lung cancer
(NSCLC). This study has focused on the technical success
and complications associated with RFA using the monopo-
lar wet electrode for the treatment of inoperable NSCLC.
MATERIALS AND METHODS
Patients: The institutional ethics committee at our
hospital approved this study, and written informed consent
was obtained from every patient prior to treatment. From
December 2003 to June 2004, 16 patients (mean age: 65.6
years, age range: 43 77 years) with NSCLC underwent
RFA using a monopolar wet electrode under CT scan
guidance. For all patients, the diagnosis of NSCLC was
obtained following a percutaneous transbronchial needle
biopsy and bronchoscopic biopsy. The patients were not
candidates for surgery because of the advanced stage of
their disease along with a poor cardiopulmonary status (n
= 12) or coexistent medical problems (n = 2) or refusal to
undergo surgery (n = 2). The patients that were selected
for RF therapy met the following criteria: (a) they had
histologically proven NSCLC, (b) no coagulation disorders,
(c) tumor size was less than 6 cm, and (d) a single primary
pulmonary tumor was present.
The tumors ranged in diameter from 3 to 6 cm (mean,
4.6  1.1 cm). There were two, nine, and five tumors < 3
cm, 3 5 cm, and > 5 cm, respectively. Two (12.5%)
patients had stage IB lung cancer and 14 patients (87.5%)
had unresectable stage III or IV lung cancer. Fourteen
patients had a forced expiratory volume in 1 second that
measured < 1 L. There were two separate justifications for
performing RFA. In the first patient group, RFA was
applied to achieve complete ablation in two patients. In
this group, the patients had stage I lung cancer but despite
our best medical advice that they undergo surgical
resection, they adamantly refused surgery (n = 2) due to
old age. In the second group, 14 patients underwent RFA
to achieve volume reduction of the primary tumor to
prevent complications or direct invasion due to the bulk
mass. Nine of 14 patients received systemic chemotherapy
after RFA regardless of technical failure due to the
presence of metastatic lymph nodes or a distant metastasis.
The remaining patients strongly refused systemic
chemotherapy.
Radiofrequency Technique: Before the procedure, all the
patients fasted for six hours and blood coagulation parame-
ters were checked. The most appropriate approach to the
lesion was selected based on the tumor location
determined by CT. The RFA procedure was performed in a
hospital CT room by a single experienced chest radiologist,
a technician and a nurse. RFA was always performed with
the patient under analgesia, which was achieved with an
intravenous administration of 50 100  g of fentanyl
citrate (Fentanyl, Myengmun, Seoul, Korea). Vital signs
were monitored continuously during the procedure and for
one hour afterward. 
Two grounding pads were established near the electrode.
All patients underwent a chest CT scan (Somatom Plus 4,
Siemens, Erlangen, Germany) immediately before RFA.
The selected axial images were obtained from within the
area of interest. The image slices were 3 mm thick. 
Radiofrequency ablation was planned in an attempt to
avoid the blood vessels, bronchi, blebs and fissures. After
cleaning the skin with iodine and alcohol, local anesthesia
was achieved by a subcutaneous injection of 1% lidocaine
from the skin down to the pleura along a predetermined
puncture line. A 16-gauge single open-perfused electrode
(Elektrotom HiTT 106, Berchtold Medizin-Eelektronik,
Tuttlingen, Germany) was then carefully introduced into
the tumor under CT guidance. In order to minimize the
incidence of a pneumothorax, an attempt was made to
limit the number of times the electrode passed through the
pleura to a single insertion. If an additional ablation was
required, the position of the needle within the tumor was
changed by withdrawing it into the superficial tissue,
changing the angle, and then inserting it back into the
target without completely withdrawing the electrode out of
the pleura.
The RFA system used for monopolar RFA consisted of a
375-kHz generator (Elektrotom HiTT 106, Berchtold
Medizin-Eelektronik) that was set to 20 30 watts, and a
single 16-gauge open-perfused electrode in the form of a
needle with a 2 cm exposed tip. A 0.9% NaCl saline
solution was used as the perfusion liquid with the flow
adjusted to 30 mL/h. RF energy was applied for 5 minutes,
and the RF was then turned off for 2-min intervals accord-
ing to the manufacturer’s recommendations. If the tumor
size was below 3 cm, RFA was applied for 10 15 minutes.
If the tumor size was 3 5 cm, RFA was applied for 15 30
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applied for more than 30 minutes (15). The impedance was
stabilized within a range of 100 to 350  using a control
mechanism. RFA was finished after an envelope of periph-
eral ground glass opacity appeared (at least > 5 mm)
around the tumor as seen on the lung CT setting and when
the temperature of the ablated zone exceeded 60 .
Imaging and assessment of the treatment response:
Technical success was defined as the completion of the RFA
without stopping the procedure because of a side effect or
complication and elimination of enhancing areas (more
than 90%) as seen on the post-contrast-enhanced follow-up
CT images compared with the post-contrast scan before
RFA (16). Non-enhanced CT scans were obtained before
and during the RFA procedures, and contrast-enhanced CT
after injecting the contrast medium (Ultravist , Schering,
Berlin, Germany) was performed immediately after
completing the RFA. The contrast-enhanced CT scans were
compared with the pre-procedural contrast-enhanced CT
scans, and the treatment response was then assessed. After
administration of the contrast agent, the previously
enhancing area that was now a non-enhancing area of the
tumor was considered to represent necrosis induced by the
RF energy. Any region in the tumor that showed continued
enhancement was considered as residual tumor. Complete
ablation was considered when the non-enhancing area at
the site of the tumor had a diameter equal to or larger than
the treated tumor, as noted on the immediate follow-up CT
scan. Partial ablation was considered achieved when a
residual enhancement zone was detected on the immediate
follow-up image (1). If partial ablation occurred after the
saline-enhanced RFA, we recommended additional therapy
such as chemotherapy or radiation therapy. On immedi-
ately follow up CT, we evaluated shape (round or not) and
the margin of the ablated zone (smooth or not). The types
of complications encountered were also noted according to
the Society of Interventional Radiology Clinical Practice
Guideline (16). Follow-up CT was performed at 1-month
and at 3-month intervals thereafter.
All the CT images were archived using a picture archiv-
ing and communication system (PACS, m-view TM;
Marotech, Korea). The maximum diameter of each ablated
zone (ablated tumor with enveloped ground glass opacity)
was calculated for all the sections and the mean value was
calculated after measuring the size of the zone on each
section on the CT scans (lung setting) that had been
performed before and immediately after RFA. The
diameters of the ablated zone before and after RFA were
compared using a paired-sample t tests using SPSS 9.0
software (SPSS Inc., Chicago, IL).
RESULTS
Table 1 summarizes the results of RF treatment accord-
ing to the patient characteristics and tumor size. The mean
follow-up interval of this study was 15  8 months (range:
Jin et al.
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Table 1. Clinical Characteristics of 16 Patients with Non-Small Cell Lung Cancer Treated with Saline-enhanced Radiofrequency
Ablation Using Monopolar Wet Electrode
Tumor  Saline Ablation Number  Size of  
Patient Age/ Histology Stage Size Power Infusion Time of Technical Ablated  Therapeutic
No. Sex (mm) (watt) (cc/hr) (min) Electrode Result Lesion (mm) Efficacy
Insertion
01 72/F Adenocarcinoma IB 35 30 30 10 1 Success 35 C
02 75/F Adenocarcinoma IB 40 30 30 30 1 Success 50 P
03 75/M Squamous IIIA 30 20 30 20 1 Success 30 C
04 73/M Squamous IIIA 50 25 30 20 2 Success 75 C
05 73/M Squamous IIIA 60 30 30 30 2 Success 60 C
06 73/M Adenocarcinoma IV 30 25 30 20 1 Success 40 C
07 74/F Adenocarcinoma IV 35 30 30 30 1 Success 50 C
08 43/M Adenocarcinoma IV 40 30 30 20 1 Failure 40 N/A
09 73/M Adenocarcinoma IV 45 20 30 20 1 Failure 40 N/A
10 48/M Squamous IV 46 25 30 40 1 Success 50 C
11 77/M Squamous IV 50 25 30 20 2 Failure 40 N/A
12 75/M Adenocarcinoma IV 50 30 30 20 2 Success 60 P
13 40/M Adenocarcinoma IV 60 25 30 20 2 Success 60 C
14 60/F Squamous IV 60 25 30 10 2 Failure 55 N/A
15 74/M Adenocarcinoma IV 60 30 30 20 2 Failure 45 N/A
16 44/F Adenocarcinoma IV 60 30 30 30 2 Failure 45 N/A
Note. C = complete necrosis on the immediate follow-up CT, P = partial necrosis on the immediate follow-up CT, N/A = not applicable9 31 months). Technical failure was observed in six
(37.5%) of 16 patients due to side effects during the
procedure: cough (n = 4) and uncontrolled pain (n = 2).
The mean number of needle electrode insertions into the
tumor mass was 1.5 (range: 1 2). The duration of the
ablation therapy ranged from 10 to 40 minutes (mean
22.5 7.7 minutes).
The changes in the tumor size were highly significant for
predicting treatment response. Table 2 summarizes the
results of RF therapy according to tumor size. In the
technically successful group of patients (n = 10), the mean
maximum diameter of the tumor before RFA and the
mean maximum diameter of the ablated zones after RFA
were 43.6  11.3 and 51  13.5 mm, respectively. There
were statistically significant differences between the mean
maximal diameter of the tumor before RFA and of the
ablated zone after RFA (p < 0.05). Complete ablation was
attained in eight (80%) of 10 lesions (Fig. 1), and partial
ablation was achieved in two (20%) of 10 lesions (Fig. 2).
Complete ablation (100%) was achieved for all tumors
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Fig. 1. 73-year-old woman with lung cancer (adenocarcinoma) in the right middle lobe. 
A. Before radiofrequency ablation, contrast-enhanced CT scans showed 3-cm, triangular-shaped, enhanced mass in right middle lobe of
lung. 
B. Monopolar electrode was inserted once within lung mass. 
C. Immediately after radiofrequency ablation, ablated zone showed almost no enhancement on contrast-enhanced CT scans and this
was judged as complete ablation. 
D. Two years later, contrast-enhanced CT scans revealed small subpleural nodule, such as fibrotic nodule, at previous ablated zone.
CDwith a mean diameter < 3 cm. The mean maximum
diameter of the tumor before RFA and the mean
maximum diameter of the ablated zones after RFA as seen
on the last follow-up CT were 4.3 cm  1.1 and 3.7 cm 
2.3, respectively. On the immediate follow-up CT, it was
believed that two patients achieved partial ablation after
RFA. One patient had a recurrence after 24 months, but
one patient showed a decreased size of the primary lung
mass on the 31-month follow-up CT, and it was thought
that this patient had achieved complete ablation. On the
follow-up CT, two of ten patients had a recurrence, and
the remainder of the patients showed no change or a
decreased size of the primary lung mass. On the immediate
CT, a round shape of the ablated zone was seen in nine
(90%) of 10 patients and a smooth margin of the ablated
zone was also seen in nine (90%) of 10 patients.
Jin et al.
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Fig. 2. 40-year-old man with lung cancer (adenocarcinoma) in right upper lobe. After undergoing radiofrequency ablation, patient
received repeated chemotherapy and radiotherapy as treatment response was only partial ablation. 
A. Before radiofrequency ablation, contrast-enhanced CT scans showed 6 cm, lobulated contoured, enhanced mass in right upper lobe
of lung. 
B. During radiofrequency ablation, monopolar electrode was inserted twice into center of mass. 
C. Immediately after radiofrequency ablation, contrast-enhanced CT scans showed peripheral, mildly enhanced rim outside ablated zone
of lung cancer (arrow). 
D. Ten months later, size of ablated zone decreased in diameter (3 cm) and radiation pneumonia in right upper lobe was observed on
contrast-enhanced CT. However, patient died from acute respiratory distress syndrome.
CDTable 3 summarizes the complications after RF therapy.
There were two major complications (2/10, 20%): a
hemothorax (n = 1) and a bronchopleural fistula (n = 1).
There were five minor complications (5/10, 50%):
pneumothoraces that required no treatment (n = 2), pleural
effusion (n = 2), and mild hemoptysis (n = 1). The
bronchopleural fistula occurred for a subpleural tumor that
was treated with two electrode insertions. Two patients
(20%) underwent a thoracostomy and surgery after RFA.
The complications in the remaining patient required no
further treatment even though hospital discharge was
delayed. Side effects included pain (n = 6) and cough (n =
6).
DISCUSSION
Until a few years ago, conventional RF treatment
performed with a monopolar or expandable electrode was
capable of producing thermal necrosis in lung lesions < 3
cm in diameter. Although lesions > 3 cm in diameter can
be treated with multiple overlapping zones of necrosis, this
task demands a repeated procedure, which can create
more complications. Moreover, the likelihood of a local
recurrence is directly related to the treatment of larger
tumors. Consequently, the maximum size of the tissue area
that can be ablated with a single treatment is of paramount
importance because it directly determines the maximum
tumor size that can be treated during a single RF applica-
tion, the number of RF applications required, and the
likelihood of achieving a complete tumor treatment (1 9).
Monopolar, dry type RFA and bipolar multiprobe array
systems have been used. However, these techniques are
not very satisfactory, even though using a power output
above 60 70 W resulted in a larger ablated zone.
Moreover, it is often difficult to ensure a proper probe
configuration when inserting multiple probes into tumors >
3 cm in diameter. As a result, regions of histological viable
residual tumors have sometimes been observed after RF
treatment of lesions > 3 cm in diameter. In this study, RFA
using a monopolar wet electrode was able to produce a
coagulation necrosis zone with a maximum diameter of 5
7 cm after one or two electrode insertions if the
procedure was technically successful. With this technique,
it was found that a saline injection could enlarge the
effective surface area of the RF electrode. The monopolar
wet electrode is easier to handle than multiple probes for
achieving coverage of the ablated zone (1, 3 5, 11 23).
Livraghi et al. (24) suggested that a continuous infusion
of 1 mL/min saline during ablation resulted in necrotic
lesions up to a maximum of 3.9 cm in diameter.
Continuous saline infusion through a monopolar electrode
increases the efficacy of RF ablation. Three possible effects
might explain the increase in the volume of necrosis
achieved with continuous saline infusion. These effects
include (a) enlargement of the effective surface area of the
RF electrode, (b) improved patient tolerance of the
increased generator output due to tissue cooling or
decreased tissue impedance, and (c) diffusion of boiling
saline into the tissues (24, 25). In this study, an attempt
was made to infuse 0.9% saline at a rate of 0.5 ml/min
during ablation, which resulted in an ablated zone up to a
maximum of 7.5 cm in diameter after inserting the
electrode twice. It is suggested that increased coagulation
can be achieved in fewer treatment sessions with continu-
ous saline infusion as compared with the use of conven-
tional RFA. The areas of coagulation were sometimes
irregular using this infused saline technique. Livraghi et al.
(24) suggested that the irregular shape of the ablation
zones created with a continuous saline infusion might be
due to two factors: the uneven diffusion of saline and the
differential diffusion of heated saline through the tissue,
which leads to necrosis along the diffusion path. However,
in our study, we found different results for the shape of
ablation zone. A regular round shape and smooth ablated
margin was seen in nine of 10 patients that had undergone
RFA with technical success. We suggest that slow
perfusion, such as the infusion of 0.9% saline at a rate of
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Table 2. Treatment Response in Relation to Tumor Size
Treatment Response
Tumor Size
< 5 cm > 5 cm Total
< 3 cm 3 5 cm
Complete ablation 2 (100) 4 (67) 2 (100) 8 (80)
Partial ablation NA 2 (33) NA 2 (20)
Total 2 6 2 10
Note. Data in parentheses are percentages, NA = not applicable
Table 3. Types of Side Effects and Complications
Type of Complication Number
Major
Hemothorax 1
Bronchopleural fistula 1
Minor
Small pneumothorax 2
Pleural effusion 2
Hemoptysis 1
Side effect
Pain 6
Cough 6
None 30.5 ml/min during ablation does not cause an irregular
shape of the ablated zone.
The rates of major complications were acceptable, and
similar to the rates associated with the dry type RFA. Two
major complications (2/10, 20%) were observed. One
hemothorax occurred in a patient with a central tumor and
one bronchopleural fistula occurred in another patient.
These problems were due to the repeated insertions near
the pleura. Although the reported rate of pneumothorax in
a larger series varied from between 5% and 30% after a
percutaneous needle biopsy, incidences as high as 60%
have been reported (26, 27). Lee et al. (4) reported
pneumothoraces in 30% of patients (9/30) after RF
ablation when using a dry-type monopolar electrode. In
this study, pneumothoraces was observed in 20% (2/10) of
patients after RF ablation. The lower incidence of a
pneumothorax after performing RFA using the monopolar
wet electrode was related to the number of electrode
insertions.
Although the incidence of a pneumothorax was low, side
effects such as pain and cough during RFA were common.
Six (37.5%) of 16 patients complained of pain despite the
administration of analgesia. These patients had a periph-
eral tumor within 3 cm from the parietal pleura. For this
reason, it was determined that a power output < 30 W was
adequate for the peripheral tumors during RFA. Two of
these patients stopped the RFA procedure before adequate
treatment had been completed because of uncontrolled
pain despite the power being set below 30 W. It is
suggested that saline-enhanced RFA should not be
performed on a subpleural mass because a low power
output needs to be selected because of intolerable pain.
Lee et al. (28) reported that pleural effusion might occur
because of spillage of hot NaCl solution into the pleural
cavity while instilling the solution. We thought that the
intractable pain might be caused by back flow of hot saline
toward the pleura. Six (37.5%) of 16 patients suffered
from cough when the rate of saline infusion was approxi-
mately 30 ml/hour. In this situation, we hesitated in
deciding whether to continue RFA or to stop the
procedure. As a result, two patients underwent successful
RFA after repositioning the electrode. However, four
patients stopped the RFA due to nonstop coughing. These
patients were in the prone position and the tumors had
cavitations or there was an open bronchus. We suggest that
infused saline might have flowed from the cavitary lung
mass or open bronchus to the proximal bronchus and this
situation may occur with persistent coughing during saline-
enhanced RFA. Hence, the use of RFA with a monopolar
wet electrode is not recommended for lung cancer with
cavitations or if it is near an open bronchus.
The study has some limitations. First, there is the lack of
histopathological proof of the completeness of coagulation
necrosis, as other researchers have provided (3 5).
However, it has been clearly demonstrated in previous
studies that a contrast-enhanced CT scan could effectively
reveal the extent of the coagulation necrosis induced by RF
ablation. In addition, most of the complete ablation on the
immediately follow-up CT showed no change or a
decreased size of the ablated zone on the last follow-up CT
(1 8). A second limitation is the number of study partici-
pants was small and we thought that the number of partici-
pants should be increased to evaluate further the therapeu-
tic response in the future.
In conclusion, despite the use of a lower power output,
RFA using a monopolar wet electrode can achieve larger
ablated zones and a lower incidence of pneumothorax.
However, this technique showed a high rate of technical
failure due to side effects such as pain and cough during
the RFA procedure. There were also limitations in achiev-
ing complete necrosis due to the irregular shape of the
created ablation zones, as shown on the follow-up CT.
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